Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sabbagh

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
ACS Chemical Biology|June 13, 2018
Targeting the FKBP51/GR/Hsp90 Complex to Identify Functionally Relevant Treatments for Depression and PTSDJonathan J Sabbagh, Ricardo A Cordova, Dali Zheng, et al.
Pathology, Research and Practice|September 19, 2023
Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failureNadeem S Butt, Maher Kurdi, Motaz M Fadul, et al.
Plos Biology|June 28, 2017
Human cyclophilin 40 unravels neurotoxic amyloidsJeremy D Baker, Lindsey B Shelton, Dali Zheng, et al.
Clinical Neurology and Neurosurgery|October 1, 2020
The longitudinal impact of COVID-19 pandemic on neurosurgical practiceKhalid Bajunaid, Abdullah Alatar, Ashwag Alqurashi, et al.
World Neurosurgery|July 24, 2020
Neurosurgical Procedures and Safety During the COVID-19 Pandemic: A Case-Control Multicenter StudyKhalid Bajunaid, Ashwag Alqurashi, Abdullah Alatar, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
ACS Chemical Biology|June 13, 2018
Targeting the FKBP51/GR/Hsp90 Complex to Identify Functionally Relevant Treatments for Depression and PTSDJonathan J Sabbagh, Ricardo A Cordova, Dali Zheng, et al.
Pathology, Research and Practice|September 19, 2023
Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failureNadeem S Butt, Maher Kurdi, Motaz M Fadul, et al.
Plos Biology|June 28, 2017
Human cyclophilin 40 unravels neurotoxic amyloidsJeremy D Baker, Lindsey B Shelton, Dali Zheng, et al.
Clinical Neurology and Neurosurgery|October 1, 2020
The longitudinal impact of COVID-19 pandemic on neurosurgical practiceKhalid Bajunaid, Abdullah Alatar, Ashwag Alqurashi, et al.
World Neurosurgery|July 24, 2020
Neurosurgical Procedures and Safety During the COVID-19 Pandemic: A Case-Control Multicenter StudyKhalid Bajunaid, Ashwag Alqurashi, Abdullah Alatar, et al.
Pageof 12